Pakistan is taking a significant step toward modernizing its healthcare system with the development of its first National Genomics Policy, aimed at addressing inherited diseases and shifting the country’s focus from treatment-based care to preventive healthcare.
Health experts believe the proposed policy could mark a transformative change in how diseases are diagnosed, managed, and prevented in Pakistan. By integrating genomics into public health planning, authorities aim to improve early detection of genetic disorders and reduce the long-term burden on the healthcare system.
The Ministry of National Health Services, Regulations and Coordination, in collaboration with the Health Services Academy, recently held a high-level consultative meeting to discuss the framework of the proposed policy. The session brought together leading specialists in genomics, genetics, molecular biology, public health, and health policy to contribute to the national roadmap.
Federal Minister for National Health Services, Regulations and Coordination Syed Mustafa Kamal emphasized the importance of shifting Pakistan’s healthcare approach from a reactive model focused on treating diseases to a proactive system centered on prevention and early intervention.
Experts at the meeting highlighted that inherited and genetic disorders contribute significantly to long-term health challenges in Pakistan. A structured genomics policy could help identify high-risk populations, improve screening programs, and guide personalized treatment strategies based on genetic profiles.
Genomics, the study of an organism’s complete set of DNA, has become a critical field in modern medicine worldwide. Countries that have integrated genomics into public health systems are increasingly using genetic data to detect diseases earlier, tailor treatments, and improve patient outcomes.
In Pakistan, the introduction of a national policy in this field is expected to strengthen research capacity, improve diagnostic infrastructure, and encourage collaboration between healthcare institutions and academic organizations. It may also pave the way for advanced medical technologies and genetic testing services to become more widely available.
The proposed policy is also expected to support efforts in tackling rare and inherited diseases, which often go undiagnosed or are detected at later stages due to limited awareness and diagnostic resources. Early identification through genomic screening could significantly improve treatment effectiveness and quality of life for patients.
Health officials believe that the initiative could play a crucial role in reducing healthcare costs over time by preventing diseases before they develop into more serious conditions. A preventive approach is also expected to ease pressure on hospitals and medical facilities across the country.
The consultation process is expected to continue as policymakers refine the draft framework and gather input from stakeholders. Once finalized, the National Genomics Policy could become a cornerstone of Pakistan’s long-term healthcare strategy.
The move reflects a growing global trend toward precision medicine and data-driven healthcare systems, positioning Pakistan to gradually adopt advanced medical practices that prioritize prevention, early diagnosis, and personalized treatment.
